Dudediligence.

MoonLake Immunotherapeutics

MLTXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$35.4MSep ’24−$45.6MDec ’24−$39.9MMar ’25−$55.2MJun ’25−$69.7MSep ’25−$62.4MDec ’25−$69.7MMar ’26−$61.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$4.6M−$65.1M−$54.1M−$143.1M−$244.8M
Net income−$4.5M−$50.0M−$36.0M−$118.9M−$227.3M
Operating cash flow−$611,071−$55.9M−$42.8M−$116.6M−$196.0M
Free cash flownone on file−$55.9M−$43.1M−$117.1M−$196.0M
Cash$8.0M$39.5M$451.2M$180.4M$334.5M
Debt$15.0M$0.00none on file$0.00$74.1M
Shares outstanding360.0M29.4M49.1M62.9M64.5M